Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Disease Management : DM
|
January 27, 2005
Type 2 diabetes and disease management: exploring the connections
Karen R Segal
The Journal of Clinical Psychiatry
|
August 2, 2003
Weight gain in the treatment of mood disorders
Louis J Aronne, Karen R Segal
American Journal of Human Biology : the Official Journal of the Human Biology Council
|
May 18, 2017
Nutritional assessment of hospital patients: New methods and new opportunities
Theodore B Van Itallie, Karen R Segal
The Physician and Sportsmedicine
|
January 2, 2018
Heart Rate Response to Ballet Stage Performance
Jerald L Cohen, Karen R Segal, William D McArdle
Diabetes Care
|
July 9, 2015
Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
Jay S Skyler, Vivian A Fonseca, Karen R Segal, et al.
Ebiomedicine
|
October 17, 2016
Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study
David K Packham, Ian R Fraser, Peter G Kerr, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
November 27, 2012
Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders
Markus Naumann, Dirk Dressler, Mark Hallett, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 6, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
Mark Hallett, Alberto Albanese, Dirk Dressler, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 19, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions
Michael B Chancellor, Elie Elovic, Alberto Esquenazi, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
December 11, 2012
Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome
Alberto Esquenazi, Alberto Albanese, Michael B Chancellor, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Disease Management : DM
|
January 27, 2005
Type 2 diabetes and disease management: exploring the connections
Karen R Segal
The Journal of Clinical Psychiatry
|
August 2, 2003
Weight gain in the treatment of mood disorders
Louis J Aronne, Karen R Segal
American Journal of Human Biology : the Official Journal of the Human Biology Council
|
May 18, 2017
Nutritional assessment of hospital patients: New methods and new opportunities
Theodore B Van Itallie, Karen R Segal
The Physician and Sportsmedicine
|
January 2, 2018
Heart Rate Response to Ballet Stage Performance
Jerald L Cohen, Karen R Segal, William D McArdle
Diabetes Care
|
July 9, 2015
Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
Jay S Skyler, Vivian A Fonseca, Karen R Segal, et al.
Ebiomedicine
|
October 17, 2016
Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study
David K Packham, Ian R Fraser, Peter G Kerr, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
November 27, 2012
Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders
Markus Naumann, Dirk Dressler, Mark Hallett, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 6, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
Mark Hallett, Alberto Albanese, Dirk Dressler, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 19, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions
Michael B Chancellor, Elie Elovic, Alberto Esquenazi, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
December 11, 2012
Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome
Alberto Esquenazi, Alberto Albanese, Michael B Chancellor, et al.
Page
of 2